Apheon Acquires Majority Stake in Longwood

July 16, 2025

Apheon, a pan‑European private equity investor, has acquired a majority stake in Longwood, a Zaragoza‑based distributor and manufacturer of high value‑added In‑Vitro Diagnostics (IVD) equipment and services focused on Next‑Generation Sequencing. Founder Antonio Raichs and CEO Miguel Giralt will remain invested and the partnership aims to expand Longwood's product offering, pursue M&A and accelerate international growth.

Buyers
Apheon
Targets
Longwood (Diagnóstica Longwood)
Sellers
Antonio Raichs and existing shareholders
Industry
Medical Devices
Location
Aragon, Spain
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.